Real world study of Onabotulinumtoxin A vs Calcitonin Gene‐Related Peptide Monoclonal Antibodies (CGRP mAbs) in patients with migraine
Latest Information Update: 17 Jul 2020
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Erenumab; Fremanezumab; Galcanezumab
- Indications Migraine
- Focus Therapeutic Use
- 17 Jul 2020 New trial record
- 20 Jun 2020 Results presented at the 62nd Annual Scientific Meeting of the American Headache Society